At the end of the 80-week trial, the average results showed: Participants on a 4 mg dose lost 29.8 pounds (lb), or about 12.7 percent of their starting body weight
Many clients see significant results within the first month, with average weight loss of 20-60 pounds over 6-12 months
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
Mounjaro, made by Eli Lilly, contains the drug tirzepatide
Balanced Blood Sugar Enhanced Cardiovascular Health Tirzepatide can significantly improve heart health, offering a holistic approach to your well-being
In European Heart Journal